Posts Tagged: Michael Garton
Aereas Aung, Michael Garton, Aaron Wheeler, and Paul Yoo are four of the BME faculty members among eighteen researchers at the University of Toronto are receiving 2024-25 Connaught Innovation Awards in support of their impactful research.
A U of T Engineering student team working on synthetic biology research and innovation has achieved its best results to date at the International Genetically Engineered Machine (iGEM) competition, with a platform to counter so-called superbugs that resist antibiotic treatment. With the support of Professors Michael Garton and Freeman Lan (both BME), the team started working with plasmids from E. coli bacteria to see if they could generate new sequences and validate their functionality, both computationally and in the wet lab.
Three faculty members at the University of Toronto’s Institute of Biomedical Engineering (BME) have been awarded Canada Research Chairs (CRCs) by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC).
Lucy Ma, a biomedical engineering graduate student, is developing iPSC-derived skeletal muscle tissues to create a sustainable cure for chronic genetic diseases like hemophilia, under the supervision of Dr. Michael Garton and Dr. Penney Gilbert. As captain of the Gold boat for the SKULE Iron Dragons, she draws on the teamwork and discipline of dragon boat racing to fuel her research and stay connected to her Asian heritage.
Meet Danielle Serra and Janice Pang, two exceptional individuals seamlessly balancing the demands of academia and their passion for curling. In this profile Q&A, the duo shares their unique journeys into the world of curling, from a chance encounter at a university event to becoming members of the University Varsity Curling team.
Researchers at the University of Toronto's Faculty of Applied Science and Engineering have successfully utilized an artificial intelligence (AI) framework to redesign a crucial protein involved in the delivery of gene therapy.
The injection of lab-made, healthy cells—referred to as a cell therapy — into a damaged heart could be a way to prevent that heart from failing. But to make this therapy a reality, the cells must be able to integrate and survive in patients’ bodies. That problem is exactly what Myoxa Therapeutics, the first-place winner at the Building a Biotech Pitch Competition, is working on solving.
A mixed filling dumpling with Myo Palate's cultivated pork and store-bought vegetable ingredients. The company has partnered with U of T Engineering professor Michael Garton (BME) on a project to further advance their technology.
The Leap into the Future series looks at emerging areas or aspects of regenerative medicine.
Medicine by Design is supporting research aimed at advancing new concepts expected to be important to regenerative medicine in the coming years. The funded projects will have potential impacts in diseases and conditions such as vision loss, amyotrophic lateral sclerosis (ALS), intestinal disease in premature babies and more.
Showing 1 - 10 of 12 results